This product accurately covers the full-length coding regions, hotspot regions, and their adjacent splice sites of 255 lymphoma-related genes. Based on hybrid capture technology, it efficiently detects various lymphoma-related variations. Meanwhile, cfDNA samples can be combined with UMI molecular tagging technology for high-depth and high-sensitivity MRD detection, providing more effective evidence for lymphoma diagnosis, efficacy evaluation, and relapse monitoring.
Technical Platform | TargetSeq® Hybridization Capture Sequencing |
Coverage Size | 513.5 kb |
Reference Database | RefSeq |
Reference Genome | GRCh38 |
Coverage | Covers the full-length coding regions, hotspot regions, and their adjacent splice sites of 255 lymphoma-related genes |
Storage | -20℃±5℃ |
Sequence Platform | Illumina / MGI |
Recommend Sequencing Read Length | PE150 |
Recommend Sequencing Data Size and Depth | 3 Gb / 2,000× |
Excellent Performance
Figure 1. Capture Data Performance Test of gDNA Standards. gDNA positive standards (Shuimu Jiheng) were used to construct libraries with an input amount of 100 ng, followed by hybrid capture and sequencing on Illumina NovaSeq 6000 (PE150).
Product Name | Panel Number | Set | Cat. No |
Lymphoma 255 Genes Panel | T2691V1hg38 | 24 rxn | PH2008305 |
96 rxn | PH2008302 |
CN
